1/49
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced |
---|
No study sessions yet.
Selective toxicity
selectively finding and destroying pathogens without damaging the host
Chemotherapy
the use of chemical to treat diseases
Antibiotic
a substance produced by a microbe that, in small amounts, inhibits another microbe ( umbrella term for both antimicrobials and drugs )
Antimicrobial drugs
synthetic substances that interfere with the frowth of microbes
antibiotics are naturally produced by
microboes
drugs are
synthetic
Streptomyces
the most studies generate for antibiotics
produced mostly antibiotics
Narrow spectrum of microbial activity
drugs that affect a narrow range of microbial types ( activity; the specific pathogen groups they can attack )
Broad-spectrum antibiotics
affect a broad range of gram-positive or gram-negative bacteria
isoniaized
efffective only against mycoacterium ( narroow)
tertracycline
effective against gram positive and gram-negative also mycobacteria, chlamydia, Rickettsia ( broad)
broad spectrum antibiotics are not the best to use because
they could lead to supper infections : overgrowth of normal microbiota ( an opportunistic pathogen part that was mart of your normal microbiota took the opportunity to grow bc antibiotic took out the competition )
Superinfection
overgrowth of normal microbiota that is resistant to antibiotics ( kills the competition )
bactericidal
kill microbes directly
Bacteriostatic
Prevent microbes from growing ( prevent dividing, not allowing the build of the cell wall )
Depending on the dose of a drug that can act
Bactericidal or Bacteriostatic
Inhibition of cell wall synthesis (MOA)
penicillin’s, cephalosporins, bacitracin, vancomycin
Inhibition of protien synthesis (MOA)
chloramphenicol, erythromycin, tetracyclines, streptomycin
inhibition of nucleic acid replication and transcription (MOA)
quinolones, rifampin
Injury to plasma memebrane (MOA)
polymyxin B
inhibition of essential metabolite synthesis
sulfanilamide,trimethopim ( compativie inhibition)
Penicillin ( inhibiting cell wall synthesis )
prevent the sysnthesis of crossbridges ( natural
low dose: prevents the making of cell wall
highdose: destorys the cell wall
semi-symphetic
natural antibiotics that were modified overcome antimicrobial resistance
ex. peneicilin is ntural SAB
beta-lactenin enzyme
what penicillin resisitent bacteria produce , attaches to the penicilin chemical and breaks it in half making it usless
specificly the beta lactam ring
enzymatic inactiviation
the abilitie of bacteria to break an antimicrobial into an enzyme
isoniazid (INH)
inhibits the mycolic acid synthesis in mycobacteria ( acid fast )
Ethambutol
Inhibits incorporation of mycolic acid into the cell wall
synergism
referring, to the use of two or more antimicrobials together which are more effective than using them independently
advantages:
can use lower doses of both rather than one high dose of one
less damage to the body
Inhibiting protein synthesis
targets bacterial 70s ribosomes in three ways
Chloramphenicol: Binds to 50s ( big subunit) portion and inhibits formation of peptide bond ( cant make DNA chain, can’t bind nucleotides )
Tetracyclines: interfere with the attachment of tRNA to mRNA the ribosome complex
Streptomycin: changes the shape of 30s portions, causing the code on mRNa to be read incorrectly ( incorrectly read, no protein )
Nitrofurantoin
converted to intermediates that attack bacteria ribosomal proteins
synthesized chemically
Treatment for urinary bladder infections
has to be processed —> it produces an intermediate byproduct to inhibit
injuring the plasma membrane
A polypeptide antibiotic changes membrane permeability
Antifungal drugs combine with membrane sterols
Has to be very specific
Injury to membranes ( synthesis )
lipopeptides
Daptomycin: attacks the bacterial cell membrane
Polymyxin B: topical; bactericidal; effective against gram-negatives
Polymyxin e ( colistin ) : effective agianst gram - negatives ( effects the transport )
nucleic acid synthesis inhibitors
Rifamycin ( rifampin) : inhibits mRNA synthesis, blocks bacterial RNA ( dosen’t effect us )
Antagonistic: increase liver metabolic activity (Don’t use with other microbial ( use by itself )
Quinolone and fluoroquinolones: Nalidixic acid, synthetic; inhibits DNA gyrase ( we don’t have this )
inhibiting the synthesis of essential metabolites ( bacterial pathogens )
Antimetabolites compete with normal substrates for an enzyme ( binds to active site) its made to compete
trimethoprim
Chloramphenicol ( IPS)
Binds to 50s ( big subunit) portion and inhibits formation of peptide bond ( cant make DNA chain, can’t bind nucleotides )
Tetracyclines (IPS)
interfere with the attachment of tRNA to mRNA the ribosome complex
Streptomycin ( IPS)
changes the shape of 30s portions, causing the code on mRNa to be read incorrectly ( incorrectly read, no protein )
trimethoprim
Inhibits the conversion of dihydromorin acid to tetrahydrofolic acid
combination of trimethoprim and sulfamethoxazole (TMP - SMZ) is an example of drug synergism
Antifungal Drugs
( selective toxic ) Usually, the first treatment of a broad spectrum if bacteria are specified
agents affecting cell membranes: ergosterol synthesis
agents affecting fungal cell walls
Polyenes & azoles - disrupt production of
imidazole’s ( AFD)
topical; treat cutaneous mycoses
Triazole ( AFD)
treat systemic fungal infections
Echinocandins
inhibit the synthesis of β-glucan ( main sugar for the cell wall )
Antiviral Drugs
two ways of preventing viral infections :
entry and fusion inhibitors
block the receptors on the host cell that bind to the virus ( covering )
Block fusion of the viruses and the cell
Preventing uncoating ( preventing DNA release)
target RDRP
inhibit viral DNA integration into the host genome ( prophage )
Antiprotozoal Drugs
not well understood
Quinine and chloroquine treat malaria
Metronidazole, Tinidazole, Nitazoxanide - also interferes with anaerobic bacteria
treats trichomonas, giardiasis, and amebic dysentery
Persister cells ( RAD)
microbes with genetic characteristics allowing for their survival when exposed to an antibiotic ( what leads to microbial resistance)
superbugs
bacteria that are resistant to a large number of antibiotics Bacterial pathogens that are resistant to nearly all antibiotic cause healthcare-associated infections.
Acinetobacter baumanniii
pseudomonas aeruginosa
members of Enterobacteriaceae
enzymatic destruction or inactivation of the drug
Mech of resistance
Pre
Prevention of penetration to the target site within the microb
Mech of resistance ( P)
Alteration of the drug’s target site
mech of resistance ( a)
Rapid efflux( ejecting ) of the antibiotic
mech of resistance ( R)